Back to News
Market Impact: 0.55

Link Ventures sells EverQuote (EVER) shares worth $20.9 million

EVERJPM
Insider TransactionsCapital Returns (Dividends / Buybacks)Corporate EarningsCompany FundamentalsAnalyst EstimatesAnalyst InsightsArtificial IntelligenceFintech
Link Ventures sells EverQuote (EVER) shares worth $20.9 million

EverQuote (NASDAQ:EVER) recently repurchased 900,000 shares at $23.33 each from Link Ventures LLLP and affiliates of its Chairman, signaling confidence amidst strong Q2 financial results including 34% revenue growth to $156.6 million and record net income of $14.7 million. While JPMorgan slightly reduced its price target to $29 citing tariff concerns, it maintains an Overweight rating, as the stock trades below analyst fair value estimates, underscoring a dynamic period for the company.

Analysis

EverQuote (NASDAQ:EVER) is executing a strategic capital return, repurchasing 900,000 shares for $21 million from a major institutional holder, Link Ventures, and its Chairman. This buyback, priced at $23.33 per share, was conducted at a discount to recent averages and signals management's confidence in the company's valuation. The move is supported by exceptionally strong financial performance, including a 34% year-over-year increase in second-quarter revenue to $156.6 million and a record net income of $14.7 million. Further reinforcing this positive fundamental picture, the company has demonstrated 93% revenue growth over the last twelve months and maintains a healthy current ratio of 3.03. While analyst consensus appears bullish with price targets ranging from $29 to $38, there is a note of caution from JPMorgan, which, despite maintaining an Overweight rating, trimmed its price target to $29 from $30 due to concerns over potential tariff impacts on second-half margins. This single point of concern slightly tempers an otherwise strong narrative of growth, profitability, and shareholder-friendly capital allocation.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo